5555-54-4Relevant academic research and scientific papers
Pyrimidin-4-one derivatives and their use in the treatment, amelioration or prevention of a viral disease
-
Paragraph 0171-0172, (2013/05/08)
The present invention relates to a compound having the general formula II, optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which is useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
-
Paragraph 0158; 0159, (2013/05/08)
The present invention relates to a compound having the general formula I, optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which is useful in treating, ameliorating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
N-(Diethoxyphosphoryl)-O-benzylhydroxylamine - A convenient substrate for the synthesis of N-substituted O-benzylhydroxylamines
B?azewska, Katarzyna,Gajda, Tadeusz
, p. 10249 - 10254 (2007/10/03)
Easily available N-(diethoxyphosphoryl)-O-benzylhydroxylamine was shown to be convenient, orthogonally protected substrate for regioselective N-alkylation by means of diverse halides under basic conditions (sodium hydride/ tetrabutylammonium bromide). An
Azolobenzazepine derivatives as neurologically active agents
-
, (2008/06/13)
PCT No. PCT/GB97/00592 Sec. 371 Date Sep. 3, 1998 Sec. 102(e) Date Sep. 3, 1998 PCT Filed Mar. 4, 1997 PCT Pub. No. WO97/32883 PCT Pub. Date Sep. 12, 1997The invention relates to azolobenzazepine derivatives of formula (I), wherein: X is O or S; R1, R2, R3 and R4 are independently hydrogen, perfluorolower-alkyl, halogen, nitro or cyano; and C together with the carbon atoms to which it is attached forms a 5-membered aromatic heterocycle selected from the group consisting of a pyrazol and triazole, to pharmaceutical compositions containing them and to methods for the treatment of neurological disorders utilizing them.
